528 related articles for article (PubMed ID: 17511951)
1. Mycosis fungoides with depigmentation secondary to treatment.
Firoz B; Kovich OI; Latkowski JA
Dermatol Online J; 2007 Jan; 13(1):18. PubMed ID: 17511951
[TBL] [Abstract][Full Text] [Related]
2. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
3. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
[TBL] [Abstract][Full Text] [Related]
4. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
Lokitz ML; Wong HK
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
[TBL] [Abstract][Full Text] [Related]
5. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
6. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
8. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
D'Acunto C; Gurioli C; Neri I
J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
[TBL] [Abstract][Full Text] [Related]
9. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
10. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo-like leucoderma during photochemotherapy for mycosis fungoides.
Mimouni D; David M; Feinmesser M; Coire CI; Hodak E
Br J Dermatol; 2001 Dec; 145(6):1008-14. PubMed ID: 11899124
[TBL] [Abstract][Full Text] [Related]
12. Phototherapy of mycosis fungoides.
Trautinger F
Photodermatol Photoimmunol Photomed; 2011 Apr; 27(2):68-74. PubMed ID: 21392108
[TBL] [Abstract][Full Text] [Related]
13. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
14. [Granulomatous mycosis fungoides histologically simulating cutaneous sarcoidosis].
Maillard H; Croué A; François S; Verret JL
Ann Dermatol Venereol; 1998 Dec; 125(12):912-5. PubMed ID: 9922868
[TBL] [Abstract][Full Text] [Related]
15. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
Huang J; Cowper S; Moss J; Girardi M
J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
17. PUVA therapy and narrowband UVB therapy in Tunisian patients with mycosis fungoides.
Khaled A; Fazaa B; Goucha S; Zeglaoui F; Kamoun MR
Therapie; 2009; 64(6):389-94. PubMed ID: 20025842
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
19. Hypopigmented mycosis fungoides in childhood and adolescence.
Neuhaus IM; Ramos-Caro FA; Hassanein AM
Pediatr Dermatol; 2000; 17(5):403-6. PubMed ID: 11085673
[TBL] [Abstract][Full Text] [Related]
20. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
Tourbier H; Schultz-Ehrenburg U
Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
